Clinical Trial Update: Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH [Phase 4]

View source ↗

Summary

Phase 4 trial exploring safety, efficacy, and treatment satisfaction when switching PAH patients from Flolan to Remodulin using the Crono Five ambulatory pump.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• FLOLAN (EPOPROSTENOL SODIUM)
• Remodulin (treprostinil)

Snippet

Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2013-07-17